Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$43.66

0.03 (0.07%)

07:18
08/07/18
08/07
07:18
08/07/18
07:18

Ionis Pharmaceuticals reports Q2 EPS (29c), consensus (9c)

Reports Q2 revenue $118M, consensus $135.48M.

  • 30

    Aug

  • 06

    Oct

IONS Ionis Pharmaceuticals
$43.66

0.03 (0.07%)

06/20/18
LEHM
06/20/18
DOWNGRADE
Target $45
LEHM
Underweight
Ionis Pharmaceuticals downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Gena Wang downgraded Ionis Pharmaceuticals (IONS) to Underweight and lowered her price target for the shares to $45 from $52 after PTC Therapeutics (PTCT) reported competing spinal muscular atrophy data. Wang this morning also upgraded PTC to Equal Weight from Underweight.
06/20/18
LEHM
06/20/18
NO CHANGE
LEHM
Barclays upgrades PTC to Equal Weight, downgrades Ionis to Underweight
Barclays analyst Gena Wang upgraded PTC Therapeutics (PTCT) to Equal Weight from Underweight while downgrading Ionis Pharmaceuticals (IONS) to Underweight from Equal Weight. The analyst raised her price target on the former to $40 from $26 and lowered her price target on the latter to $45 from $52. Following PTC's new data in spinal muscular atrophy data, the analyst believes its risdiplam has "disruptive potential" to Ionis and Biogen's (BIIB) Spinraza.
07/11/18
PIPR
07/11/18
NO CHANGE
Target $50
PIPR
Neutral
Ionis approval narrower than expected, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren says the European approval of Tegsedi announced this morning Ionis Pharmaceuticals (IONS) and Akcea Therapeutics (AKCA) for the treatment of stage 1 or stage 2 polyneuropoathy in adult patients with hATTR was narrower than he originally expected. The indication is narrower than the broader hATTR patient population, inclusive of both cardiomyopathy and polyneuropathy, but makes sense considering that the pivotal trial primarily enrolled patients with stage 1 and 2 polyneuropathy, Van Buren tells investors in a research note. The analyst adds that while the approval is a positive development and Tegsedi represents the largest near-term pipeline opportunity for Ionis, he wants to observe positive early launch metrics and confirmation of the opportunity before getting more constructive on the shares. He keeps a Neutral rating on Ionis with a $50 price target.
07/23/18
OPCO
07/23/18
NO CHANGE
Target $400
OPCO
Outperform
Oppenheimer anticipating potential volatility ahead for Biogen
Oppenheimer analyst Jay Olson anticipates Biogen (BIIB) volatility driven by Q2 results along with AD presentations at AAIC that include promising BAN2401 data, which was recently top-lined. The analyst expects a focus on ADCOMS component scores and effect sizes for BAN2401. With regards to Q2 results, Olson expects top-line growth of 4% and non-GAAP EPS of $3.95 which is impacted by the Ionis Pharmaceuticals (IONS) deal upfront payment. Additionally, he expects continued strong Spinraza and biosimilar growth. Olson reiterates an Outperform rating and $400 price target on Biogen's shares.

TODAY'S FREE FLY STORIES

BKH

Black Hills

$64.40

0.92 (1.45%)

18:24
11/20/18
11/20
18:24
11/20/18
18:24
Hot Stocks
Black Hills Energy receives approval to construct $54M gas pipeline in Wyoming »

Black Hills announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,026.00

7 (0.69%)

, GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

18:19
11/20/18
11/20
18:19
11/20/18
18:19
Periodicals
Google expands Moffett Park presence again, SVBJ says »

Google is once again…

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

SE

Sea Limited

$12.18

-0.52 (-4.09%)

18:04
11/20/18
11/20
18:04
11/20/18
18:04
Earnings
Sea Limited reports Q3 net loss ($237.6M) vs. ($127.1M) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.61

0.575 (4.41%)

18:03
11/20/18
11/20
18:03
11/20/18
18:03
Earnings
Bilibili reports Q3 revenue $157.1M, consensus $146.72M »

Reports Q3 adjusted net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LTM

Latam Airlines

$9.24

-0.4 (-4.15%)

18:01
11/20/18
11/20
18:01
11/20/18
18:01
Hot Stocks
Breaking Hot Stocks news story on Latam Airlines »

LATAM Airlines reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CE

Celanese

$100.26

-1.53 (-1.50%)

18:01
11/20/18
11/20
18:01
11/20/18
18:01
Hot Stocks
Celanese increases Fortron polyphenylene sulphide price by 85c per kg »

The price increases will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$317.77

-3.09 (-0.96%)

, TSLA

Tesla

$347.60

-5.88 (-1.66%)

17:55
11/20/18
11/20
17:55
11/20/18
17:55
Periodicals
NASA to investigate workplace culture at Boeing, SpaceX, Reuters says »

NASA said that it plans…

BA

Boeing

$317.77

-3.09 (-0.96%)

TSLA

Tesla

$347.60

-5.88 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 13

    Dec

PLWTY

Panalpina World Transport

$0.00

(0.00%)

17:52
11/20/18
11/20
17:52
11/20/18
17:52
Upgrade
Panalpina World Transport rating change  »

Panalpina World Transport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

17:52
11/20/18
11/20
17:52
11/20/18
17:52
Hot Stocks
British Columbia sets path for 100% zero-emission vehicle sales by 2040 »

In a move aimed at…

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$117.29

0.2 (0.17%)

F

Ford

$9.06

-0.19 (-2.05%)

HMC

Honda

$27.60

-0.46 (-1.64%)

GM

General Motors

$35.09

-0.58 (-1.63%)

FCAU

Fiat Chrysler

$15.83

-0.585 (-3.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

SPY

SPDR S&P 500 ETF Trust

$264.12

-5.16 (-1.92%)

, SPX

S&P 500

$0.00

(0.00%)

17:45
11/20/18
11/20
17:45
11/20/18
17:45
General news
U.S says China has not changed its 'unfair' trade practices »

The Office of the United…

SPY

SPDR S&P 500 ETF Trust

$264.12

-5.16 (-1.92%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBA

Ritchie Bros.

$34.27

-0.24 (-0.70%)

17:42
11/20/18
11/20
17:42
11/20/18
17:42
Recommendations
Ritchie Bros. analyst commentary  »

Ritchie Bros exhibiting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Earnings
Breaking Earnings news story on Foot Locker »

Foot Locker sees Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FE

FirstEnergy

$37.96

-0.58 (-1.50%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Periodicals
FirstEnergy in pact to sell West Lorain facility to Starwood Energy, WSJ says »

FirstEnergy Generation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$90.53

-3.14 (-3.35%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Hot Stocks
National Beverage announces special cash dividend of $2.90 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$65.31

-0.81 (-1.23%)

17:30
11/20/18
11/20
17:30
11/20/18
17:30
Syndicate
Breaking Syndicate news story on Oshkosh »

Oshkosh files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:27
11/20/18
11/20
17:27
11/20/18
17:27
Hot Stocks
MDU Resources sees 2019-2023 CapEx $2.6B »

"We have identified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:26
11/20/18
11/20
17:26
11/20/18
17:26
Earnings
MDU Resources narrows FY18 EPS view to $1.30-$1.45 from $1.25-$1.45 

FY18 consensus $1.39.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:22
11/20/18
11/20
17:22
11/20/18
17:22
Earnings
Foot Locker backs FY18 EPS growth view in double digits, consensus $4.48 »

Backs FY18 SSS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:19
11/20/18
11/20
17:19
11/20/18
17:19
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker sees Q4 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:17
11/20/18
11/20
17:17
11/20/18
17:17
Hot Stocks
Foot Locker says women's business was the strongest in footwear »

Says pleased by Foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CPRT

Copart

$47.30

-1.255 (-2.58%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Earnings
Copart reports Q1 fully diluted EPS 47c, consensus 47c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Hot Stocks
DexCom and Verily amend license agreementAlphabet Class A »

DexCom (DXCM) and Verily,…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

VNET

21Vianet

$11.20

-0.1 (-0.88%)

17:12
11/20/18
11/20
17:12
11/20/18
17:12
Earnings
21Vianet reports Q3 adjusted EBITDA up 81.6% to RMB 45.2M »

Reports Q3 revenue RMB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

DXCM

DexCom

$119.89

-1.34 (-1.11%)

17:05
11/20/18
11/20
17:05
11/20/18
17:05
Syndicate
Breaking Syndicate news story on DexCom »

DexCom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

RDC

Rowan Companies

$14.32

-0.74 (-4.91%)

, ESV

Ensco

$6.19

-0.36 (-5.50%)

17:02
11/20/18
11/20
17:02
11/20/18
17:02
Hot Stocks
Rowan Companies and Ensco granted early termination of waiting period »

Rowan Companies (RDC) and…

RDC

Rowan Companies

$14.32

-0.74 (-4.91%)

ESV

Ensco

$6.19

-0.36 (-5.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.